 lacunar stroke, and poor life expectancy.138 A network
meta-analysis showed no superiority for aspirin with
rivaroxaban over clopidogrel alone for the primary composite endpoint in the chronic PAD subgroups of CAPRIE
and COMPASS.139 Therefore in the absence of a RCT
directly comparing the two, both clopidogrel alone and
aspirin with rivaroxaban are reasonable choices for secondary cardiovascular prevention for patients with
